⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8013847 | 0.81 | — | — | |
| SCHEMBL16938728 | 0.77 | — | — | |
| SCHEMBL5174119 | 0.76 | TP53 (0.34) | — | |
| SCHEMBL2052969 | 0.73 | — | — | |
| SCHEMBL8033380 | 0.73 | — | — | |
| SCHEMBL2174113 | 0.73 | — | — | |
| SCHEMBL11294617 | 0.73 | — | — | |
| SCHEMBL17034111 | 0.73 | — | — | |
| SCHEMBL12322226 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL2324407 | 0.71 | MEN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2350042-B1 | NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPHY | CPL BCX PHARMA AB (SE) | 2015-07-29 | — | — | EP | disclosed |
| US-9012656-B2 | Oligothiophene derivate as molecular probes | CELLUMINOVA AB (SE) | 2015-04-21 | — | — | US | disclosed |
| US-9012656-B2 | Oligothiophene derivate as molecular probes | CELLUMINOVA AB (SE) | 2015-04-21 | — | — | US | disclosed |
| EP-2536712-B1 | OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES | CELLUMINOVA AB (SE) | 2015-03-18 | — | — | EP | disclosed |
| US-8710246-B2 | Substituted thiophene pentamers | BIOCHROMIX NEWCO AB (SE) | 2014-04-29 | — | — | US | disclosed |
| US-8710246-B2 | Substituted thiophene pentamers | BIOCHROMIX NEWCO AB (SE) | 2014-04-29 | — | — | US | disclosed |
| US-20120315646-A1 | OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES | CELLUMINOVA AB (SE) | 2012-12-13 | — | — | US | disclosed |
| US-20120315646-A1 | OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES | CELLUMINOVA AB (SE) | 2012-12-13 | — | — | US | disclosed |
| US-20120157516-A1 | NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPY | BIOCHROMIX PHARMA AB | 2012-06-21 | — | — | US | disclosed |
| US-20120157516-A1 | NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPY | BIOCHROMIX PHARMA AB | 2012-06-21 | — | — | US | disclosed |
| WO-2011102789-A1 | OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES | OBOE IPR AB (SE) | 2011-08-25 | — | — | WO | disclosed |
| WO-2010044743-A1 | NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPHY | BIOCHROMIX PHARMA AB (SE) | 2010-04-22 | — | — | WO | disclosed |
| WO-2010044744-A1 | NOVEL THIOPHENE COMPOUNDS FOR IN VIVO IMAGING | BIOCHROMIX AB (SE) | 2010-04-22 | — | — | WO | disclosed |